Method of treating the syndrome of lipodystrophy
First Claim
Patent Images
1. A method of treating a human suffering from the Syndrome of Lipodystrophy or one or more HIV-related abnormalities included therein, the method comprising:
- administering, by a pharmaceutically effective mode, a drug composition comprising an opioidergic composition.
3 Assignments
0 Petitions
Accused Products
Abstract
Methods of treating a human suffering from the Syndrome of Lipodystrophy or one or more HIV-related abnormalities included therein are provided. One method may include administering, by a pharmaceutically effective mode, a drug composition comprising an opioidergic agent, or alternatively, an opioidergic agent and an insulin secretagogue. The method may also include administering, by a pharmaceutically effective mode, a drug composition comprising an opiate agonist and opiate antagonist, or alternatively, an opiate agonist, opiate antagonist and an insulin secretagogue.
52 Citations
48 Claims
-
1. A method of treating a human suffering from the Syndrome of Lipodystrophy or one or more HIV-related abnormalities included therein, the method comprising:
administering, by a pharmaceutically effective mode, a drug composition comprising an opioidergic composition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)
-
28. A method of treating a human suffering from the Syndrome of Lipodystrophy or one or more HIV-related abnormalities included therein, the method comprising:
administering, by a pharmaceutically effective mode, a drug composition comprising an opioidergic composition and at least one insulin secretagogue. - View Dependent Claims (29, 30, 31, 32, 33, 34, 35, 36, 37, 38)
-
39. A method of treating a human suffering from the Syndrome of Lipodystrophy or one or more HIV-related abnormalities included therein, the method comprising:
administering, by a pharmaceutically effective mode, a drug composition comprising at least one opiate agonist; and
at least one opiate antagonist. - View Dependent Claims (40, 41, 42, 43, 44, 45, 46, 47, 48)
Specification